| Literature DB >> 28469121 |
Fadimatu Bakari1, Muhammad A Abdul1, Saad A Ahmed2.
Abstract
BACKGROUND: In spite of knowledge of the causes and prevention of cervical cancer, screening programs for cervical cancer have not yet been fully implemented in most developing countries including Nigeria. Documented data on the prevalence of preinvasive cervical lesion in pregnancy are scarce in our environment.Entities:
Mesh:
Year: 2017 PMID: 28469121 PMCID: PMC5452714 DOI: 10.4103/aam.aam_35_16
Source DB: PubMed Journal: Ann Afr Med ISSN: 0975-5764
Sociodemographic and reproductive profile
| Variable | Frequency (%) |
|---|---|
| Age of respondent | |
| <20 | 7 (2.8) |
| 20-29 | 132 (52.8) |
| 30-39 | 109 (43.6) |
| ≥40 | 2 (0.8) |
| Total | 250 (100) |
| Tribe | |
| Hausa | 123 (49.2) |
| Fulani | 14 (5.6) |
| Yoruba | 30 (12.0) |
| Igbo | 13 (5.2) |
| Others | 70 (28.0) |
| Total | 250 (100) |
| Educational level | |
| Quranic | 15 (6.0) |
| Primary | 15 (6.0) |
| Secondary | 80 (32.0) |
| Tertiary | 139 (55.6) |
| None | 1 (0.4) |
| Total | 250 (100) |
| Marital status | |
| Married | 249 (99.6) |
| Single | 1 (0.4) |
| Total | 250 (100) |
| Parity group | |
| <5 | 222 (88.8) |
| ≥5 | 28 (11.2) |
| Total | 250 (100) |
| Gestational age (weeks) | |
| <13 | 30 (12) |
| 13-26 | 145 (58) |
| >26 | 75 (30) |
| Total | 250 (100) |
Prevalence of preinvasive cervical lesion in pregnancy at booking
| Report of Pap smear at booking | Frequency (%) |
|---|---|
| Preinvasive | 15 (6) |
| Nonpreinvasive | 235 (94) |
| Total | 250 (100) |
Cytopathology report at booking
| Cytopathology report | Frequency (%) |
|---|---|
| Negative | 158 (63.2) |
| Inflammatory | 63 (25.2) |
| LGSIL | 13 (5.2) |
| HGSIL | 2 (0.8) |
| Candida | 7 (2.8) |
| Herpes | 1 (0.4) |
| HPV effect | 2 (0.8) |
| Inadequate | 4 (1.6) |
| Total | 250 (100) |
LGSIL=Low-grade squamous intraepithelial lesion, HGSIL=High-grade squamous intraepithelial lesion, HPV=Human papillomavirus
Comparison of antenatal Pap smear with postpartum cytopathology smear
| Status | Booking | Postpartum (%) |
|---|---|---|
| LGSIL | 13 | Negative: 2 (15.4) |
| LGSIL: 9 (69.2) | ||
| Loss to follow-up: 2 (15.4) | ||
| HGSIL: 0 | ||
| HGSIL | 2 | LGSIL: 1 (50) |
| HGSIL: 1 (50) | ||
| Total | 15 | 15% |
LGSIL=Low-grade squamous intraepithelial lesion, HGSIL=High-grade squamous intraepithelial lesion
Figure 1(a) Below depicts the course of low-grade squamous intraepithelial lesion in pregnancy
Influence of sociodemographic and reproductive profile on preinvasive cervical lesion
| Variable | Frequency (%) | Test | ||
|---|---|---|---|---|
| Preinvasive | Nonpreinvasive | |||
| Age of respondents (years) | ||||
| <20 | 0 | 7 (100) | Chi-square | 0.085 |
| 20-29 | 5 (3.8) | 127 (96.2) | ||
| 30-39 | 10 (9.2) | 99 (90.8) | ||
| ≥40 | 0 | 2 (100) | ||
| Total | 15 (6) | 235 (94.0) | ||
| Tribe | ||||
| Hausa | 6 (4.9) | 117 (95.1) | Chi-square | 0.58 |
| Fulani | 0 | 14 (100) | ||
| Yoruba | 2 (6.7) | 28 (93.3) | ||
| Igbo | 1 (7.7) | 12 (92.3) | ||
| Others | 6 (8.6) | 64 (91.4) | ||
| Total | 15 (6) | 235 (94) | ||
| Educational level | ||||
| Quranic | 0 | 15 (100) | Chi-square | 0.02 |
| Primary | 2 (13.3) | 13 (86.7) | ||
| Secondary | 7 (8.8) | 73 (91.2) | ||
| Tertiary | 5 (3.6) | 134 (96.4) | ||
| None | 1 (100) | 0 | ||
| Total | 15 (6) | 235 (94) | ||
| Parity group | ||||
| <5 | 12 (5.4) | 211 (94.6) | Fisher exact | 0.21 |
| ≥5 | 3 (11.1) | 24 (88.9) | ||
| Total | 15 (6) | 235 (94.0) | ||
| Gestational age | ||||
| <13 | 1 (3.3) | 29 (96.7) | Chi-square | 0.60 |
| 13-26 | 8 (5.5) | 137 (94.5) | ||
| >26 | 6 (8.0) | 69 (92) | ||
| Total | 15 (6) | 235 (194) | ||
Influence of risk factors on preinvasive cervical lesion
| Variable | Frequency (%) | Test | ||
|---|---|---|---|---|
| Preinvasive | Nonpreinvasive | |||
| Age at coitarche | ||||
| <16 | 6 (17.1) | 29 (82.9) | Fisher’s exact | 0.010 |
| ≥16 | 9 (4.2) | 206 (95.8) | ||
| Total | 15 (6) | 235 (94.0) | ||
| Sexual partners since coitarche | ||||
| 1 | 4 (2.4) | 163 (97.6) | Chi-square | 0.001 |
| 2 | 4 (7.8) | 47 (92.2) | ||
| ≥3 | 7 (21.9) | 25 (78.1) | ||
| Total | 15 (6) | 235 (94) | ||
| Previous STI | ||||
| Yes | 10 (9.6) | 94 (90.4) | Chi-square | <0.001 |
| No | 3 (2.1) | 141 (97.9) | ||
| HIV | 2 (100) | 0 | ||
| Total | 15 (6) | 235 (94) | ||
| Parity group | ||||
| <5 | 12 (5.4) | 210 (94.6) | Fisher’s exact | 0.21 |
| ≥5 | 3 (10.7) | 25 (89.3) | ||
| Total | 15 (6) | 235 (94) | ||
| Smoking | ||||
| Yes | 1 (50) | 1 (50) | Fisher’s exact | 0.12 |
| No | 14 (5.6) | 234 (94.4) | ||
| Total | 15 (6) | 235 (94) | ||
| Use of contraception | ||||
| Yes | 6 (7.1) | 78 (92.8) | Fisher’s exact | 0.38 |
| No | 9 (5.4) | 157 (94.6) | ||
| Total | 15 (6) | 235 (94) | ||
HIV=Human immunodeficiency virus